Author:
Marshall John,McEachern Kerry Anne,Chuang Wei-Lien,Hutto Elizabeth,Siegel Craig S.,Shayman James A.,Grabowski Greg A.,Scheule Ronald K.,Copeland Diane P.,Cheng Seng H.
Subject
Genetics(clinical),Genetics
Reference41 articles.
1. Aerts JM, Ottenhoff R, Powlson AS et al (2007) Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 56:1341–1349
2. Beutler E, Grabowski GA (2001) Gaucher disease. In: Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease (Scriver CR). McGraw-Hill, New York, pp 3635–3668
3. Brady RO, Kanfer JN, Bradley RM, Shapiro D (1966) Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher’s disease. J Clin Invest 45:1112–1115
4. Charrow J, Andersson HC, Kaplan P et al (2004) Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations. J Pediatr 144:112–120
5. Cox TM, Aerts JM, Andria G et al (2003) The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type 1 (non-neuropathic) Gaucher disease: a position statement. J Inherit Metab Dis 26:513–526
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献